Abbott Ordered to Pay $53M in Preterm Formula Trial Jury awards $53 million on Apr 10, 2026, reviving scrutiny of Abbott's 2022 plant shutdown that removed ~40% of US powdered formula output (Investing.com; Reuters).

Abbott Ordered to Pay $53M in Preterm Formula Trial: Jury awards $53 million on Apr 10, 2026, reviving scrutiny of Abbott's 2022 plant shutdown that removed ~40% of US powdered formula output (Investing.com;… 👈 Read full analysis #Abbott #FormulaRecall #ChildNutrition #LegalNews #PretermFormula